Main
>
ONCOLOGY (**)
>
Breast Cancer>HR+>HER2->MET ***
>
Treatment
>
CH. N. Ribociclib+ **
>
(*) USA Approval Date: 2017. 03.13.
(*) USA Approval Date: 2017. 03.13.'s products
This section has no products